Some diabetes medications, while improving cognitive dysfunction, also enhance synaptic dysfunction by upregulating synaptic proteins including PSD 95, brain‐derived neurotrophic factor (BDNF), SYP, and synapsin‐1 (SYN1) in DACD rodent models [219, 220, 221]. This evidence concerns the gene BDNF and diabetes mellitus.